ABT vs MRK

Abbott Laboratories against Merck & Co. — live side-by-side technical comparison.

Prices as of 2026-10-16T20:03:40+00:00 UTC · updates daily

Who leads right now

MRK leads 3 of the 5 windows we measure — over 1 month ABT is +2.5% and MRK +0.7%; over year to date ABT is -16.3% and MRK +38.7%. The ABT/MRK price ratio stands at 0.7187, below its 50-day average of 0.7308, and below the 200-day average of 0.8315. A ratio above its own average means ABT is gaining on MRK; on this reading the recent edge belongs to MRK.

Performance side by side

ABTMRK
Price$104.89 $145.95
1 day +0.2% +0.5%lead
5 days +5.3%lead +0.2%
1 month +2.5%lead +0.7%
6 months +9.9% +26.4%lead
Year to date -16.3% +38.7%lead
52-week position 46% of range 85% of range
52-week range $81.97–$132.03 $82.01–$156.92
vs 50-day average below $105.87 above $145.12
vs 200-day average above $102.81 above $124.87
RSI (14) 62 45
Next earnings 2026-10-212026-10-29

Where each one stands

ABT — Abbott Laboratories

ABT trades at $104.89, below its 50-day average of $105.87, and above the 200-day at $102.81. It sits at 46% of its 52-week range ($81.97–$132.03); 14-day RSI is 62, in neutral territory; an average session moves it about 2.3%. For levels, the first level overhead is $105.87 (0.9% away) and the first support below is $104.55 (0.3% down). On the checklist the page runs for every asset, 5 of 6 checks read bullish — the lean is bullish.

MRK — Merck & Co.

MRK trades at $145.95, above its 50-day average of $145.12, and above the 200-day at $124.87. It sits at 85% of its 52-week range ($82.01–$156.92); 14-day RSI is 45, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $150.00 (2.8% away) and the first support below is $145.12 (0.6% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.

Which one moves harder

MRK is the more volatile of the two — an average session moves it 2.7% against 2.3% for ABT, so an identical position size carries roughly 1.2× the daily risk.

What would change the picture

The comparison turns on those levels: ABT clearing $105.87 or losing $104.55; MRK clearing $150.00 or losing $145.12. Until one of them gives way, the relative reading above stands.

Questions people ask about ABT vs MRK

Which is performing better right now, ABT or MRK?
Over the past month ABT is +2.5% and MRK is +0.7%, so ABT is ahead on that window. Year to date the figures are -16.3% for ABT and +38.7% for MRK.
Is ABT or MRK more volatile?
MRK is the more volatile of the two — an average session moves it 2.7% against 2.3% for ABT, so an identical position size carries roughly 1.2× the daily risk.
What are the key levels for ABT and MRK?
ABT: resistance $105.87, support $104.55; MRK: resistance $150.00, support $145.12. Levels come from recent swing zones and round numbers, recomputed daily.
When do ABT and MRK report next?
ABT: 2026-10-21. MRK: 2026-10-29. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the ABT/MRK ratio mean?
It is simply ABT's price divided by MRK's — 0.7187 today. When the ratio rises, ABT is outperforming; when it falls, MRK is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

ABT →
Abbott Laboratories
Full technical brief: trend, levels, chart, news
MRK →
Merck & Co.
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs UNHLLY vs MRKLLY vs TMOAMGN vs LLYGILD vs LLYABT vs LLY